Scientists Say They ’ve Reached Turning Point in Cancer Research With Vaccines
SEATTLE — The next big advance in cancer treatment could be a vaccine.
After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years.
These aren’t traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer, with gains reported this year for deadly skin cancer melanoma and pancreatic cancer.
More from TIME
[video id=W5jcvwLu autostart="viewable"]
“We’re getting something to work. Now we need to get...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Carla K. Johnson / AP Tags: Uncategorized Cancer wire Source Type: news
Telix to acquire Lightpoint Medical for $20M
Telix Pharmaceuticals has entered a $20 million agreement to acquire th...Read more on AuntMinnie.comRelated Reading:
First patient dosed in phase II Telix Starburst trial
Telix acquires Dedicaid for $1.2M
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 21, 2023 Category: Radiology Source Type: news
First patient dosed in phase II Telix Starburst trial
The first patient has been dosed in Telix Pharmaceuticals' carbonic anhydrase-targetin...Read more on AuntMinnie.comRelated Reading:
Telix acquires Dedicaid for $1.2M
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results
Telix relocates U.S. headquarters (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 19, 2023 Category: Radiology Source Type: news
ASCO: Adding Atezolizumab to Cabozantinib No Benefit in Advanced Renal Cancer
FRIDAY, June 9, 2023 -- For patients with locally advanced or metastatic renal cell carcinoma with disease progression on or after immune checkpoint inhibitor treatment, the addition of atezolizumab to cabozantinib does not improve clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 9, 2023 Category: Pharmaceuticals Source Type: news
No Survival Benefit With Immune Checkpoint Inhibitor Rechallenge in Metastatic RCC
(MedPage Today) -- CHICAGO -- Adding atezolizumab (Tecentriq) to cabozantinib (Cabometyx) for patients with metastatic renal cell carcinoma (RCC) after progression on an immune checkpoint inhibitor failed to improve clinical outcomes and led... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 6, 2023 Category: Hematology Source Type: news
Cabozantinib Plus Nivolumab and Ipilimumab Increases PFS in Renal Cell Cancer
THURSDAY, May 11, 2023 -- Cabozantinib plus nivolumab and ipilimumab yields significantly longer progression-free survival than treatment with cabozantinib plus nivolumab alone among patients with previously untreated, advanced renal-cell carcinoma... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 11, 2023 Category: Pharmaceuticals Source Type: news
Kidney cancer warning signs to look for as half of cases are symptomless
Many patients do not realise they have kidney cancer until it is picked up by unrelated medical tests. (Source: Daily Express - Health)
Source: Daily Express - Health - May 11, 2023 Category: Consumer Health News Source Type: news
S2 Episode 2: How Single-Cell Sequencing Can Help in Renal Cell Carcinoma S2 Episode 2: How Single-Cell Sequencing Can Help in Renal Cell Carcinoma
Drs Sumanta Pal and David A. Braun discuss the role of single-cell sequencing as a biomarker in renal cell carcinoma, how it is evolving, and how it might apply in other domains.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
S2 Episode 1: Tissue Biomarkers and Renal Cell Carcinoma S2 Episode 1: Tissue Biomarkers and Renal Cell Carcinoma
Drs Sumanta Pal and Scott Haake discuss the biology of kidney cancer and how to incorporate tissue biomarkers into prospective studies on renal cell carcinoma.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 3, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
Upfront Systemic Therapy, Deferred Surgery Pass Muster in Advanced Kidney Cancer
(MedPage Today) -- CHICAGO -- Perioperative immunotherapy for advanced kidney cancer did not adversely affect outcomes with cytoreductive nephrectomy and appeared to have several beneficial effects, a small multicenter study showed.
Primary... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 2, 2023 Category: Hematology Source Type: news
Telix acquires Dedicaid for $1.2M
Telix Pharmaceuticals has acquired Vienna, Austria-based Dedicaid, a spin-of...Read more on AuntMinnie.comRelated Reading:
Telix gets FDA nod for gallium injection prep kit
Telix makes two new executive appointments
Telix highlights kidney cancer imaging study results
Telix relocates U.S. headquarters
Telix obtains Health Canada clearance for Illuccix (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2023 Category: Radiology Source Type: news
How to Find Support When You Have Metastatic Kidney Cancer
Nearly two years after he’d been treated for kidney cancer and felt like he was in the clear, Chuck Stravin received the news that some nodules in both of his lungs were growing at an aggressive pace. When those were removed and biopsied, results confirmed that his kidney cancer had become metastatic.
“Everything switched in that moment—the battle became completely different,” he recalls. “Before, we were focused on moving fast and being cancer-free, and then I had to flip a switch and slow down. I had to change my mindset, and I knew I couldn’t do that alone.”
[time-brightcove not...
Source: TIME: Health - April 25, 2023 Category: Consumer Health News Authors: Elizabeth Millard Tags: Uncategorized Cancer healthscienceclimate Source Type: news
7 Myths About Kidney Cancer, Debunked
Kidney cancer may well be the least-known common cancer in the U.S. An estimated 81,800 new cases will be diagnosed this year, according to the American Cancer Society. In 2022, the disease was the eighth most common cancer, occurring more frequently than leukemia and thyroid cancer. Yet, when people are diagnosed, their reaction is often, “I didn’t even know you could get cancer of the kidneys,” says Dr. Alice C. Fan, an assistant professor of medicine in the division of oncology at Stanford University School of Medicine in Palo Alto, Calif.
Humans have two fist-sized kidneys (shaped like the eponymous b...
Source: TIME: Health - April 19, 2023 Category: Consumer Health News Authors: Katherine Hobson Tags: Uncategorized Cancer healthscienceclimate Source Type: news
CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancer
(MedPage Today) -- ORLANDO -- An off-the-shelf, allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD70 demonstrated antitumor activity in patients with advanced clear cell renal cell carcinoma (RCC), according to results from... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 19, 2023 Category: Hematology Source Type: news
Identical twins suffer SAME cancer symptoms - even though only one of them has the disease
Sophie Walker, from Edinburgh, was diagnosed with a Wilms' tumour - a type of kidney cancer - in 2017. The 16-year-old has gone into remission three times - but sadly relapsed in December. (Source: the Mail online | Health)
Source: the Mail online | Health - April 17, 2023 Category: Consumer Health News Source Type: news
